Back

Standalone Bio-Interventional Uveoscleral Outflow Enhancement for Intraocular Pressure Reduction in Open-Angle Glaucoma: One-Year Results from a Prospective Multicenter Real-World Evidence Study (NCT05506423)

2025-12-15 ophthalmology Title + abstract only
View on medRxiv
Show abstract

This prospective, multicenter, real-world evidence study evaluates the 12-month safety and effectiveness of standalone cyclodialysis with AlloFlo cleft reinforcement for intraocular pressure (IOP) reduction in open-angle glaucoma (OAG). AlloFlo represents the worlds first acellular, allogenic scleral tissue implant, and data from this CREST Study cohort (NCT05506423) contribute critical long-term safety and effectiveness knowledge to the field of extracellular matrix biomaterials research, in ad...

Predicted journal destinations